Specifically, the LIMD1 gene responds to hypoxia through an HIF1-α response element in its promoter and, as a protein, acts as a scaffold to stabilize the PHD2/VHL/HIF-1α degradation complex, in this sense working as a tumor suppressor [46]. The gene discussed is EGLN1; the disease is neoplasm.